Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
479 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05651321 | Studies on the Impact of Taste-aware Intelligent Analysis of Oral Nutritional Supplements | unknown | — | 108 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05802394 | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer(MAP-03) | recruiting | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 |
| Apr 12, 2023 |
| clinicaltrials |
| NCT05802407 | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer(MAP-02) | recruiting | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05802420 | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer(MAP-01) | unknown | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05288569 | irAE Prediction of Anti-PD-1/L1 in Lung Cancer | unknown | — | 120 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05803915 | Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy | unknown | Phase 2 | 57 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05804916 | Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer | recruiting | Phase 2 / Phase 3 | 556 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05802381 | the Safety and Effectiveness of Protein Supplements on Cancer Patients With Nutritional Risk and Malnutrition | unknown | N/A | 100 | Peking Union Medical College HospitalOTHER | 0 | Apr 6, 2023 | clinicaltrials |
| NCT03892577 | Real-world Study for Patients With Advanced Hepatobiliary Tumors | unknown | — | 3,000 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT03895970 | Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors | completed | Phase 2 | 32 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT04010071 | Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT04211168 | Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers | unknown | Phase 2 | 44 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT04368078 | Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 76 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT04443309 | Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC | unknown | Phase 1 / Phase 2 | 53 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT04646837 | Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models | unknown | Phase 1 / Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05048017 | Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05771207 | Effects of Protein on Muscle, Gut Microbiota and Clinical Outcome in Patients With Lung Cancer-related Sarcopenia | unknown | N/A | 90 | Peking Union Medical College HospitalOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT05752773 | Prediction of Myocardial Injury After Laparoscopic Pheochromocytoma/ParaGangLioma Resection(MI-PPGL) | unknown | — | 700 | Peking Union Medical College HospitalOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT05536427 | Safety and Efficacy of IPM001 in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 1 | 24 | Peking Union Medical College HospitalOTHER | 1 | Mar 2, 2023 | clinicaltrials |
| NCT05445310 | Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer | unknown | Phase 2 | 114 | Peking Union Medical College HospitalOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05728515 | A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma | completed | Early Phase 1 | 3 | Peking Union Medical College HospitalOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05729737 | Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer | unknown | — | 100 | Peking Union Medical College HospitalOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05722977 | Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients | not yet recruiting | Phase 2 | 45 | Peking Union Medical College HospitalOTHER | 0 | Feb 10, 2023 | clinicaltrials |
| NCT05689138 | Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer | unknown | — | 100 | Peking Union Medical College HospitalOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT05680194 | Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients(EEBC) | unknown | — | 1,000 | Peking Union Medical College HospitalOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT04049942 | Comparing the Impact of Multimodal Prehabilitation to Aerobic Training on Patients Undergoing Thoracoscopic Lobectomy | unknown | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Dec 28, 2022 | clinicaltrials |
| NCT05662488 | FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy | unknown | — | 25 | Peking Union Medical College HospitalOTHER | 1 | Dec 22, 2022 | clinicaltrials |
| NCT05636150 | A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 48 | Peking Union Medical College HospitalOTHER | 1 | Dec 5, 2022 | clinicaltrials |
| NCT05637034 | 68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer | unknown | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Dec 5, 2022 | clinicaltrials |
| NCT05634798 | An Observational Study Based on Endometrial Cancer Risk Screening Model | unknown | — | 2,000 | Peking Union Medical College HospitalOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05627778 | 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis | unknown | Phase 1 / Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 | Nov 28, 2022 | clinicaltrials |
| NCT05524389 | Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions | not yet recruiting | Phase 3 | 624 | Peking Union Medical College HospitalOTHER | 0 | Nov 23, 2022 | clinicaltrials |
| NCT05622240 | 99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Nov 21, 2022 | clinicaltrials |
| NCT05622227 | 68Ga PET/CT Imaging in Breast Cancer Patients | unknown | Phase 1 / Phase 2 | 50 | Peking Union Medical College HospitalOTHER | 1 | Nov 18, 2022 | clinicaltrials |
| NCT05532384 | Effect of Early Postoperative Drinking Water on Postoperative Recovery Quality of Patients With Thyroid Surgery | unknown | N/A | 94 | Peking Union Medical College HospitalOTHER | 1 | Nov 15, 2022 | clinicaltrials |
| NCT05593393 | A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm | unknown | — | 1,500 | Peking Union Medical College HospitalOTHER | 0 | Nov 14, 2022 | clinicaltrials |
| NCT05613270 | Characterizing Breast Cancer With 18F-FES PET/CT | unknown | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05432947 | 68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients | completed | N/A | 42 | Peking Union Medical College HospitalOTHER | 1 | Nov 3, 2022 | clinicaltrials |
| NCT05604716 | Cross-sectional Follow-up on Digestive and Social Functions of SPN | unknown | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Nov 3, 2022 | clinicaltrials |
| NCT05601401 | Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2 | unknown | Phase 2 | 10 | Peking Union Medical College HospitalOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05003427 | 68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT03589833 | Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA(YISTAR) | completed | Phase 4 | 504 | Peking Union Medical College HospitalOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT05034783 | [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients | unknown | Early Phase 1 | 20 | Peking Union Medical College HospitalOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT05531981 | Detection of Minimal Residual Disease Based on HPV ctDNA in Cervical Cancer | unknown | — | 350 | Peking Union Medical College HospitalOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT05569434 | 68Ga-P16-093 PET/CT Imaging in Glioma Patients | unknown | Phase 1 / Phase 2 | 50 | Peking Union Medical College HospitalOTHER | 1 | Oct 6, 2022 | clinicaltrials |
| NCT03747588 | The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer(MIOPP) | recruiting | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT04267900 | 99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer | completed | Early Phase 1 | 34 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2022 | clinicaltrials |
| NCT05023564 | PUMCH Dementia Longitudinal Cohort Study | recruiting | — | 20,000 | Peking Union Medical College HospitalOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT03478358 | Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors | unknown | Phase 1 | 60 | Peking Union Medical College HospitalOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT05499936 | 68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC) | unknown | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Aug 12, 2022 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials